Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006

Catherine C Cowie, Keith F Rust, Danita D Byrd-Holt, Edward W Gregg, Earl S Ford, Linda S Geiss, Kathleen E Bainbridge, Judith E Fradkin, Catherine C Cowie, Keith F Rust, Danita D Byrd-Holt, Edward W Gregg, Earl S Ford, Linda S Geiss, Kathleen E Bainbridge, Judith E Fradkin

Abstract

OBJECTIVE We examined prevalences of previously diagnosed diabetes and undiagnosed diabetes and high risk for diabetes using recently suggested A1C criteria in the U.S. during 2003-2006. We compared these prevalences to those in earlier surveys and those using glucose criteria. RESEARCH DESIGN AND METHODS In 2003-2006, the National Health and Nutrition Examination Survey included a probability sample of 14,611 individuals aged > or =12 years. Participants were classified on glycemic status by interview for diagnosed diabetes and by A1C, fasting, and 2-h glucose challenge values measured in subsamples. RESULTS Using A1C criteria, the crude prevalence of total diabetes in adults aged > or =20 years was 9.6% (20.4 million), of which 19.0% was undiagnosed (7.8% diagnosed, 1.8% undiagnosed using A1C > or =6.5%). Another 3.5% of adults (7.4 million) were at high risk for diabetes (A1C 6.0 to <6.5%). Prevalences were disproportionately high in the elderly. Age-/sex-standardized prevalence was more than two times higher in non-Hispanic blacks and Mexican Americans versus non-Hispanic whites for diagnosed, undiagnosed, and total diabetes (P < 0.003); standardized prevalence at high risk for diabetes was more than two times higher in non-Hispanic blacks versus non-Hispanic whites and Mexican Americans (P < 0.00001). Since 1988-1994, diagnosed diabetes generally increased, while the percent of diabetes that was undiagnosed and the percent at high risk of diabetes generally decreased. Using A1C criteria, prevalences of undiagnosed diabetes and high risk of diabetes were one-third that and one-tenth that, respectively, using glucose criteria. CONCLUSIONS Although A1C detects much lower prevalences than glucose criteria, hyperglycemic conditions remain high in the U.S., and elderly and minority groups are disproportionately affected.

Figures

Figure 1
Figure 1
Undiagnosed diabetes in the U.S. population aged ≥20 years by three diagnostic criteria—NHANES 2005–2006. Comparisons were calculated among individuals in the OGTT subsample in 2005–2006 (n = 2,017); consequently some estimates may differ slightly from those in Table 1. The thresholds of diagnostic criteria for diabetes were A1C ≥6.5%, FPG ≥7.0 mmol/1, and 2-h glucose ≥11.1 mmol/1. Point estimates (%) and 95% CIs for the categories are: A1C alone = 0.3 (0.0–0.7); FPG alone = 0.2 (0.0–0.5); 2-h glucose alone = 2.5 (1.9–3.2); A1C and FPG not 2-h glucose = 0.0; A1C and 2-h glucose not FPG = 0.1 (0.0–0.3); FPG and 2-h glucose not A1C = 1.0 (0.3–1.8); A1C, FPG, and 2-h glucose = 1.2 (0.5–2.0); total A1C = 1.6 (0.7–2.5); total FPG = 2.5 (1.2–3.8); total 2-h glucose = 4.9 (3.4–6.4); diagnosed diabetes = 7.8 (6.7–8.8); nodiabetes = 86.9 (84.6–89.1).

References

    1. The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327–1334
    1. Centers for Disease Control and Prevention, National Center for Health Statistics. National Health and Nutrition Examination Survey 1988–1994, 1999–2002, 2003–2006 [information online], 2009. Available from . Accessed 1 March 2009
    1. Little RR, Wiedmeyer HM, England JD, Wilke AL, Rohlfing CL, Wians FH, Jr, Jacobson JM, Zellmer V, Goldstein DE: Interlaboratory standardization of measurements of glycohemoglobins. Clin Chem 1992;38:2472–2478
    1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009;32 (Suppl. 1):S62–S67
    1. U.S. Census Bureau, Population Division. Table 1: annual estimates of the population by five-year age groups and sex for the United States: April 1, 2000 to July 1, 2006 (NC-EST2006-01) [information online], 2003–2006. Available from . Accessed 17 May 2009
    1. Research Triangle Institute. SUDAAN User's Manual, Release 9.0.1. Research Triangle Park, NC, Research Triangle Institute, 2005.
    1. LaVange LM, Stearns SC, Lafata JE, Koch GG, Shah BV: Innovative strategies using SUDAAN for analysis of health surveys with complex samples. Stat Methods Med Res 1996;5:311–329
    1. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, Geiss LS: Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006. Diabetes Care 2009;32:287–294
    1. Pani LN, Korenda L, Meigs JB, Driver C, Chamany S, Fox CS, Sullivan L, D'Agostino RB, Nathan DM: Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001–2004. Diabetes Care 2008;31:1991–1996
    1. Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, Lachin JM, Montez MG, Brenneman T, Barrett-Connor E: Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007;30:2453–2457
    1. Selvin E, Crainiceanu CM, Brancati FL, Coresh J: Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007;167:1545–1551
    1. National Glycohemoglobin Standardization Program. National Glycohemoglobin Standardization Program [article online]. Available from . Accessed 23 October 2009
    1. Little RR, Sacks DB: HbA1c: how do we measure it and what does it mean? Curr Opin Endocrinol Diabetes Obes 2009;16:113–118
    1. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403
    1. American Diabetes Association. Standards of medical care in diabetes: 2009. Diabetes Care 2009;32(Suppl. 1):S13–S61

Source: PubMed

3
Předplatit